Open Access
Retraction: miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2
Oncology Research · 2026 · 34 (5) · 1-10
DOI: 10.32604/or.2026.081623 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Oncology Research Editorial Office. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Oncology Research Editorial Office (2026). Retraction: miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2. Oncology Research, 34(5), 1-10. https://doi.org/10.32604/or.2026.081623
Vancouver
Oncology Research Editorial Office. Retraction: miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2. Oncology Research. 2026;34(5):1-10. doi:10.32604/or.2026.081623
BibTeX
@article{OncologyResearchEditorialOffice2026,
author = {Oncology Research Editorial Office, Oncology Research Editorial Office},
title = {Retraction: miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2},
journal = {Oncology Research},
year = {2026},
volume = {34},
number = {5},
pages = {1--10},
doi = {10.32604/or.2026.081623}
}
EUVIMED